Diabetes and Blood Clotting: A Study on APTT and Fibrinogen Levels
Author Information
Author(s): Zhao Ying Zhang, Jie Zhang, Juanwen Wu, Jianping
Primary Institution: The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Hypothesis
This study examines the relationship between shortened activated partial thromboplastin time (APTT) and increased fibrinogen values with diabetes mellitus.
Conclusion
Shorter APTT and increased fibrinogen levels might be useful hemostatic markers in patients with diabetes and in patients at high risk for diabetes.
Supporting Evidence
- Diabetic patients showed significantly shorter APTT values compared to non-diabetic groups.
- Increased fibrinogen levels were observed in diabetic patients.
- Shortened APTT values may indicate a higher risk of thromboembolic complications in diabetes.
Takeaway
People with diabetes have shorter blood clotting times and higher levels of a protein that helps blood clot, which could mean they are at higher risk for blood clots.
Methodology
APTT, PT, fibrinogen, fasting plasma glucose (FPG) and glycosylated hemoglobin A1c (HbA1c) levels were measured in 1,300 patients, who were divided into groups based on their HbA1c and FPG levels.
Limitations
The study excluded patients with certain conditions that could affect coagulation, which may limit the generalizability of the findings.
Participant Demographics
817 men and 483 women; median age 64 years (range 39–83 years).
Statistical Information
P-Value
p<0.001
Confidence Interval
1.9–6.3 g/L
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website